Sg3 Management, LLC Biogen Inc. Call Options Transaction History

Sg3 Management, LLC

$0
Q3 2023

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $5.77 Million - $6.58 Million	-22,500 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $1.46 Million - $1.78 Million	5,800 Added 25.78%	28,300 $7.84 Million
Q3 2022 May 15, 2023	SELL	$194.69 - $268.46 $1.13 Million - $1.56 Million	-5,800 Reduced 20.49%	22,500 $6.01 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $5.32 Million - $7.33 Million	-27,300 Reduced 54.82%	22,500 $6.01 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.05 Million - $1.25 Million	-5,600 Reduced 10.11%	49,800 $10.2 Million

Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $4.98 Million - $6.27 Million	-25,700 Reduced 31.69%	55,400 $11.7 Million
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $3.34 Million - $4.29 Million	-14,900 Reduced 15.52%	81,100 $19.5 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $23.3 Million - $30.4 Million	-82,400 Reduced 46.19%	96,000 $27.2 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $29.8 Million - $47.7 Million	-114,900 Reduced 39.17%	178,400 $61.8 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $49 Million - $57.4 Million	201,500 Added 219.5%	293,300 $82.1 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $8.29 Million - $12.5 Million	35,100 Added 61.9%	91,800 $22.5 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $15 Million - $17.3 Million	56,700 New	56,700 $16.1 Million
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $4.03 Million - $5.12 Million	-15,000 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $3.3 Million - $4.56 Million	15,000 New	15,000 $4.45 Million
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $1.77 Million - $2.5 Million	-6,800 Closed	0 $0
Q4 2017 Feb 26, 2018	BUY	$307.64 - $344.58 $2.07 Million - $2.32 Million	6,732 Added 9900.0%	6,800 $2.17 Million
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $20,919 - $23,431	68 New	68 $3,000
Q1 2017 Jan 25, 2018	SELL	N/A	-42,000 Closed	0 $0
Q4 2016 Feb 23, 2018	BUY	N/A	41,580 Added 9900.0%	42,000 $11 Million
Q4 2016 Jan 24, 2018	BUY	N/A	420	420 $134,000

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.78 Billion
0.07% of portfolio
Primecap Management CO Pasadena, CA

16.2M
Shares

$3.7 Billion
2.65% of portfolio
Black Rock Inc. New York, NY

14.1M
Shares

$3.23 Billion
0.07% of portfolio
State Street Corp Boston, MA

6.75M
Shares

$1.54 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.17M
Shares

$1.18 Billion
0.68% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Account